Doxorubicin-loaded chitosan methacrylate / methylcellulose hydrogel scaffold
Doxorubicin-loaded chitosan methacrylate / methylcellulose hydrogel scaffold has been studied in 1 paper since 2024: none in people yet, 1 in cells. No study of it in people or animals has been published yet. The newest paper, Dec 18, 2024: “Three-Dimensional Printing of Hydrogel Blend Tissue Engineering Scaffolds with In Situ Delivery of Anticancer Drug for Treating Melanoma Resection-Induced Tissue…”.
1 paper studies it1 findingUpdated
- 1 lab in 1 country
- Funders: Hong Kong Research Grants Council and 1 more
- Cells1
What did studies of Doxorubicin-loaded chitosan methacrylate / methylcellulose hydrogel scaffold find?
1Studies of Doxorubicin-loaded chitosan methacrylate / methylcellulose hydrogel scaffold measured 1 outcome; the most studied are cell viability (1 study).
Cell viability
upin rat cells1
1 study
Cell viability
upin rat cells1
Doxorubicin-loaded chitosan methacrylate / methylcellulose hydrogel scaffold improves cell viability in rat cells.
“Within the 14-day culture period, rBMSCs encapsulated in multilayered scaffolds that were incorporated with DOX displayed rejuvenated cell viability.”
Cellsbone marrow14-day
Journal of functional biomaterials